KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Clinical trial NCT03236246 · COMPLETED
Trial details
- NCT number
- NCT03236246
- Sponsor
- Keryx Biopharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-15
- Primary completion
- 2019-08-30
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.